Nonpeptidic SH2 inhibitors of the tyrosine kinase ZAP-70

Bioorganic and Medicinal Chemistry Letters

Volumn 9, Issue 20, 1999, Pages 3009-3014

  Vu, Chi B ^a,b   Corpuz, Evelyn G ^a   Pradeepan, Selvaluxmi G ^a   Violette, Shelia ^a   Bartlett, Catherine ^a   Sawyer, Tomi K ^a  

^a ARIAD PHARMACEUTICALS INC   (United States)

^b Biegen Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,4 OXADIAZOLE DERIVATIVE; DRUG ANALOG; FUNCTIONAL GROUP; PEPTIDE; PROTEIN TYROSINE KINASE INHIBITOR; SULFONE DERIVATIVE; TYROSINE; UNCLASSIFIED DRUG; UREA DERIVATIVE; ZAP 70 SULFIDE;

ARTICLE; BINDING AFFINITY; CHEMICAL MODIFICATION; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; STRUCTURE ACTIVITY RELATION;

ENZYME INHIBITORS; FLUORESCENCE POLARIZATION; PROTEIN BINDING; PROTEIN-TYROSINE KINASES; SRC HOMOLOGY DOMAINS; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 0033581630     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(99)00524-7     Document Type: Article

References (24)

1. For a review on the biological significance of SH2 domains see: Pawson, T.; Gish, G. D. Cell 1992, 71, 359.
2. (a) Wange, R. L.; Malek, S. N.; Desiderio, S.; Samelson, L. E. J. Biol. Chem. 1993, 268, 19797.
3. (b) Wange, R. L.; Isakov, N.; Burke, T. R.; Otaka, A.; Roller, P. P.; Watts, J. D.; Aebersold, R.; Samelson, L. E. J. Biol. Chem. 1995, 270, 944.
4. (c) Kersh, E. N.; Shaw, A. S.; Allen, P. Science 1998, 281, 572.
5. Hatada, M. H.; Lu, X.; Laird, E. R.; Green, J.; Morgenstern, J. P.; Lou, M.; Marr, C. S.; Phillips, T. B.; Ram, M. K.; Theriault, K.; Zoller, M. J.; Karas, J. L. Nature 1995, 377, 32.
6. Vu, C. B.; Corpuz, E. G.; Merry, T. J.; Pradeepan, S. G.; Bartlett, C.; Bohacek, R.; Botfield, M. C.; Eyermann, C. J.; Lynch, B. A.; MacNeil, I. A.; Ram, M. K.; van Schravendijk, M. R.; Violette, S.; Sawyer, T. K. J. Med. Chem., 1999, in press.
7. A series of mono and bidentate ZAP-70 SH2 inhibitors has recently been reported: Revesz, L.; Blum, E.; Manning, U.; Demange, B. J.; Widmer, A.; Zuber, J.-F. Bioorg. Med. Chem. Lett. 1997, 7, 2875.
8. Nonpeptidic monodentate ZAP-70 SH2 inhibitors have also been reported: Revesz, L.; Bonne, F.; Manning, U.; Zuber, J.-F. Bioorg. Med. Chem. Lett. 1998, 8, 405.
9. Gilmer, T.; Rodriguez, M.; Jordan, S.; Crosby, R.; Alligood, K.; Green, M.; Kimery, M.; Wagner, C.; Kinder, D.; Charifson, P.; Kassel, A. M.; Willard, D.; Luther, M.; Rusnak, D.; Sternbach, D. D.; Mehrotra, M.; Peel, M.; Shampine, L.; Davis, R.; Robbins, J.; Patel, I. R.; Kassel, D.; Burkhart, W.; Moyer, M.; Bradshaw, T.; Berman, J. J. Biol. Chem. 1994, 269, 31711.
10. For a review on Src SH2 inhibitors see: Sawyer, T. K. Biopolymers 1998, 47, 243.
11. (a) Furet, P.; Gay, B.; Cavaratti, G.; García-Echeverría, C.; Rahuel, J.; Schoepfer, J.; Fretz, H. J. Med. Chem. 1998, 41, 3442.
12. (b) Schoepfer, J.; Gay, B.; Caravatti, G.; García-Echeverría, C.; Fretz, H.; Rahuel, J.; Furet, P. Bioorg. Med. Chem. Lett. 1998, 8, 2865.
13. Silverberg, L. J.; Dillon, J. L.; Vemishetti, P. Tetrahedron Lett. 1996, 37, 111.
14. 2O that were buffered with 0.1% TFA.
15. Plummer, M. S.; Holland, D. R.; Shahripour, A.; Lunney, E. A.; Fergus, J. H.; Marks, J. S.; McConnell, P.; Mueller, W. T.; Sawyer, T. K. J. Med. Chem. 1997, 40, 3719.
16. Takeuchi, C.; Bohacek, R.; Shakespeare, W.; ARIAD Pharmaceuticals, unpublished results.
17. Lynch, B. A.; Loiacono, K. A.; Tiong, C. L.; Adams, S. E.; MacNeil, I. A. Anal. Biochem. 1997, 247, 77.
18. Shahripour, A.; Plummer, M. S.; Lunney, E. A.; Para, K. S.; Stankovic, C. J.; Rubin, J. R.; Humblet, C.; Fergus, J. H.; Marks, J. S.; Herrera, R.; Hubbell, S. E.; Saltiel, A. R.; Sawyer, T. K. Bioorg. Med. Chem. Lett. 1996, 6, 1209.
19. Evans, D. A.; Ennis, M. D.; Mathre, D. J. J. Am. Chem. Soc. 1982, 104, 1737.
20. 3. The methyl ester group was then hydrolyzed using aqueous NaOH. The resulting acid was converted to the acid chloride using oxalyl chloride.
21. Plattner, J. J.; Marcotte, P. A.; Kleinert, H. D.; Stein, H. H.; Greer, J.; Bolis, G.; Fung, A. K. L.; Bopp, B. A.; Luly, J. R.; Sham, H. L.; Kempf, D. J.; Rosenberg, S. H.; Dellaria, J. F.; De, B.; Merits, I.; Perun, T. J. J. Med. Chem. 1988, 31, 2277.
22. Plattner, J. J.; Marcotte, P. A.; Kleinert, H. D.; Stein, H. H.; Greer, J.; Bolis, G.; Fung, A. K. L.; Bopp, B. A.; Luly, J. R.; Sham, H. L.; Kempf, D. J.; Rosenberg, S. H.; Dellaria, J. F.; De, B.; Merits, I.; Perun, T. J. J. Med. Chem. 1988, 31, 2277.
23. (b) Nakano, M.; Atsuumi, S.; Koike, Y.; Tanaka, S.; Funabashi, H.; Hashimoto, J.; Morishima, H. Tetrahedron Lett. 1990, 31, 1569.
24. Beck, G.; Jendralla, H.; Kammermeier, B. Tetrahedron 1994, 50, 4691.